Page 2 - Afirma Genomic Sequencing Classifier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brokerages Set Veracyte, Inc (NASDAQ:VCYT) PT at $27 50

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12 […]

United kingdomUnited statesWilliam blairKarin easthamGoldman sachs groupInvestment managementUnited kingdom plcVeracyte incMorgan stanleyQube research technologies ltdNeedham companyGet free reportMarketbeat ratingsDirector karin easthamForest capital managementTechnologies ltd

Needham & Company LLC Lowers Veracyte (NASDAQ:VCYT) Price Target to $27 00

Needham & Company LLC Lowers Veracyte (NASDAQ:VCYT) Price Target to $27 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKarin easthamNeedham companyVeracyte incMorgan stanleyChina universal asset management coAssetmark incSg americas securitiesFinancial services group incNational bancorpVeracyte company profileGoldman sachs groupFree reportModerate buyGet free report

Veracyte, Inc (NASDAQ:VCYT) Shares Sold by E Fund Management Co Ltd

Veracyte, Inc (NASDAQ:VCYT) Shares Sold by E Fund Management Co Ltd
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesWilliam blairKarin easthamNeedham companyVeracyte incExchange commissionNational bancorpMorgan stanleyLos angeles capital managementChina universal asset management coAssetmark incFund management coE fund management coGoldman sachs groupFree report

Veracyte (NASDAQ:VCYT) Issues Earnings Results, Beats Expectations By $0 17 EPS

Veracyte (NASDAQ:VCYT) Issues Earnings Results, Beats Expectations By $0 17 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKarin easthamVeracyte incGoldman sachs groupMorgan stanleyNeedham companySecurities exchange commissionGet free reportDirector karin easthamExchange commissionAfirma genomic sequencing classifierDecipher prostate biopsyRadical prostatectomyProsigna breast cancer assayPercepta nasal swab test

Veracyte (NASDAQ:VCYT) Posts Earnings Results

Veracyte (NASDAQ:VCYT) Posts Earnings Results
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairKarin easthamVeracyte incNeedham companyMorgan stanleyGoldman sachs groupGet free reportDirector karin easthamAfirma genomic sequencing classifierDecipher prostate biopsyRadical prostatectomyProsigna breast cancer assayPercepta nasal swab testEnvisia genomic classifierVeracyte daily